Lenalidomide
Lenalidomide ATC Code L04AX04 : Antineoplastic and immunomodulating agents - Immunosuppressants drugs - Immunosuppressants drugs - Other immunosuppressants - Lenalidomide
Latin | Lenalidomidum |
---|---|
Routes | Oral |
Pregnancy category | X |
FDA Approval Date | 2005-12-27 |
EMA Approval Date | 2007-06-14 |
Molecular Formula | C13H13N3O3 |
Molecular Weight | 259.26062 g/mol |
CAS Number | 191732-72-6 |
Lenalidomide list of brand/trade names
- Germany: Revlimid
- Spain: Revlimid
- Italy: Revlimid
- Russia: Revlimid
- Australia: Revlimid
- Netherlands: Revlimid
- Belgium: Revlimid
- Denmark: Revlimid
- Greece: Revlimid
- Ireland: Revlimid
- Norway: Revlimid
- Portugal: Revlimid
- Sweden: Revlimid
- Switzerland: Revlimid
- Turkey: Revlimid
Lenalidomide ATC Code L04AX04
Antineoplastic and immunomodulating agents
Immunosuppressants drugs
Immunosuppressants drugs
Other immunosuppressants
Antineoplastic and immunomodulating agents
Immunosuppressants drugs
Immunosuppressants drugs
Other immunosuppressants